SCHEMBL9707476

SCHEMBL9707476

COC(=O)Cn1c(=O)n(C)c(=O)c2c1nc(C)n2Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 6/20 0.41
▸ TP53 P04637 1/20 0.41
▸ AGTR1 P30556 2/20 0.41
▸ AGTR2 P50052 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HPGD P15428 1/20 0.40
▸ LMNA P02545 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ GAA P10253 1/20 0.40
▸ PPARG P37231 1/20 0.39
▸ POLB P06746 2/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ PCSK9 Q8NBP7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9708749 0.94 KMT2A (0.44) AGTR1AGTR2KMT2AMEN1CYP2C9
SCHEMBL9707851 0.92 AGTR1 (0.43) AGTR1AGTR2KMT2APPARG
SCHEMBL9707465 0.91 KMT2A (0.44) AGTR1AGTR2KMT2AMEN1CYP2C9
SCHEMBL9707859 0.91 DCTPP1 (0.40) AGTR1AGTR2KMT2AMEN1CYP2C9
SCHEMBL9708279 0.91 AGTR1 (0.45) TSHRTP53AGTR1AGTR2KMT2A
SCHEMBL9707754 0.90 KMT2A (0.42) TSHRAGTR1AGTR2KMT2AMEN1
SCHEMBL9707791 0.90 AGTR1 (0.40) AGTR1AGTR2KMT2ALMNAGAA
SCHEMBL9707544 0.90 KMT2A (0.41) TSHRAGTR1AGTR2KMT2AMEN1
SCHEMBL9707556 0.90 AGTR1 (0.40) TSHRTP53AGTR1AGTR2KMT2A
SCHEMBL9707591 0.89 KMT2A (0.44) TSHRAGTR1AGTR2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 — — WO disclosed
Send feedback